This book examines the politics of cancer, explains how our
government is intrinsically tied to cancer research efforts, and
documents how major political actors make cancer policy and are
influenced in their decision making by political, social,
scientific, and economic variables. Is whether we contract
cancer—and whether we survive the disease, if we get it—largely
just a result of good versus bad luck, or are these outcomes
regarding cancer tied to the policies and actions of our federal
government? Cancer-treating drug development and approval is
overseen by the U.S. Food and Drug Administration, billions of
dollars of federal money are devoted towards cancer research, and
exposure of citizens to potentially cancer-causing environments or
chemicals is regulated by the Environmental Protection Agency.
Additionally, all of these factors can be affected by the political
motivations of our most powerful politicians. The Politics of
Cancer: Malignant Indifference analyzes the policy environment of
cancer in America: the actors, the political institutions, the
money, and the disease itself, identifying how haphazard U.S.
government policy toward cancer research has been and how the
president, Congress, government bureaucracies, and even the cancer
industry have failed to meet timelines and make the expected
discoveries. Whitman Cobb examines funding for the National Cancer
Institute and the roles of the executive, Congress, policy
entrepreneurs, and the bureaucracy as well as that of the state of
cancer science. She argues that despite the so-called "war on
cancer," no strategic, comprehensive government policy has been
imposed—leading to an indecisive cancer policy that has
significantly impeded cancer research. Written from a political
science perspective, the book enables readers to gain insight into
the realities of science policy and the ways in which the federal
government is both the source of funding for much of cancer
research and often deficient in setting comprehensive and
consistent anti-cancer policy. Readers will also come to understand
how Congress, the president, the bureaucracy, and the cancer
industry all share responsibility for the current state of cancer
policy confusion and consider whether pharmaceutical companies,
for-profit cancer treatment hospitals, and interest groups like the
American Cancer Society have a personal incentive to keep the fight
alive.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
Welcome to Loot.co.za!
Sign in / Register |Wishlists & Gift Vouchers |Help | Advanced search
